OpenLegislation

Paragraph 4

F1The participant may, without being subject to any resulting detriment, withdraw from the clinical trial at any time by revoking his informed consent.

Annotations

Textual amendments

F1

Words in Sch. 1 Pt. 3 substituted (28.4.2026) by The Medicines for Human Use (Clinical Trials) (Amendment) Regulations 2025 (S.I. 2025/538), regs. 1(2), 37(5)

Notes on Schedule 1

Textual amendments

F1

Word in Sch. 1 heading substituted (28.4.2026) by The Medicines for Human Use (Clinical Trials) (Amendment) Regulations 2025 (S.I. 2025/538), regs. 1(2), 37(2)